Epigenetic aging of human blood cells is influenced by the age of the host body
Open Access
- 4 March 2024
- journal article
- research article
- Published by Wiley in Aging Cell
- Vol. 23 (5) , e14112
Abstract
Allogenic hematopoietic stem cell transplantation is a therapeutic procedure performed over a wide range of donor and recipient age combinations, representing natural experiments of how the age of the recipient affects aging in transplanted donor cells in vivo. We measured DNA methylation and epigenetic aging in donors and recipients and found that biological epigenetic clocks are accelerated in cells transplanted into an older body and decelerated in a younger body. This is the first evidence that the age of the circulating environment influences human epigenetic aging in vivo.Keywords
Funding Information
- Kreftforeningen
- Norges Forskningsråd
This publication has 18 references indexed in Scilit:
- Biological age is increased by stress and restored upon recoveryCell Metabolism, 2023
- Heterochronic parabiosis induces stem cell revitalization and systemic rejuvenation across aged tissuesCell Stem Cell, 2022
- Epigenetic age is a cell‐intrinsic property in transplanted human hematopoietic cellsAging Cell, 2019
- Development of an Unrelated Donor Selection Score Predictive of Survival after HCT: Donor Age Matters MostTransplantation and Cellular Therapy, 2018
- An epigenetic biomarker of aging for lifespan and healthspanAging, 2018
- DNA methylation age of human tissues and cell typesGenome Biology, 2013
- Genome-wide Methylation Profiles Reveal Quantitative Views of Human Aging RatesMolecular Cell, 2013
- The ageing systemic milieu negatively regulates neurogenesis and cognitive functionNature, 2011
- Rejuvenation of aged progenitor cells by exposure to a young systemic environmentNature, 2005
- Telomere length changes in patients undergoing hematopoietic stem cell transplantationBone Marrow Transplantation, 1999